Sedat ŞEN,
Murat TERZİ
Why are the First-Line Therapies Used as Injections Discontinued in the Treatment of Multiple Sclerosis?
Why are the First-Line Therapies Used as Injections Discontinued in the Treatment of Multiple Sclerosis?
International Archives of Medical Research
2022-Cilt: 14 - Sayı: 1
7-13
Multiple sclerosis,
immunomodulatory therapy,
interferon beta,
glatiramer acetate
6119